| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 8 | NIH | 9/27/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $305,614 ) |
| | 2020 | 2020 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | 41124 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 8 | NIH | 7/1/2020 | $305,614 |
| | 2020 | 2018 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | 41124 | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 000 | 4 | NIH | 1/25/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $305,614 ) |
| | 2019 | 2019 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | 41124 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 7 | NIH | 6/26/2019 | $305,614 |
|
| Issue Date FY: 2018 ( Subtotal = $760,978 ) |
| | 2018 | 2018 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | 41124 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 6 | NIH | 6/15/2018 | $305,614 |
| | 2018 | 2018 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | 41124 | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 000 | 4 | NIH | 7/25/2018 | $455,364 |
|
| Issue Date FY: 2017 ( Subtotal = $751,072 ) |
| | 2017 | 2017 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | 41124 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 5 | NIH | 6/22/2017 | $305,614 |
| | 2017 | 2017 | GOTEBORGS UNIVERSITET | VASAPARKEN | GOTEBORG | | 41124 | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 000 | 3 | NIH | 7/19/2017 | $445,458 |
|
| Issue Date FY: 2016 ( Subtotal = $778,510 ) |
| | 2016 | 2016 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 003 | 2 | NIH | 9/8/2016 | -$472,896 |
| | 2016 | 2016 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 000 | 2 | NIH | 7/18/2016 | $472,896 |
| | 2016 | 2016 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 4 | NIH | 6/22/2016 | $305,614 |
| | 2016 | 2016 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 004 | 2 | NIH | 9/12/2016 | $472,896 |
| | 2016 | 2015 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 002 | 1 | NIH | 9/7/2016 | $447,089 |
| | 2016 | 2015 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 001 | 1 | NIH | 9/5/2016 | -$447,089 |
|
| Issue Date FY: 2015 ( Subtotal = $667,121 ) |
| | 2015 | 2015 | GOTEBORGS UNIVERSITET | VASPARKEN BOX 100 | GOTEBORG | | | | SWE | R01DK105948 | Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies. | 000 | 1 | NIH | 9/23/2015 | $447,089 |
| | 2015 | 2015 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 002 | 3 | NIH | 8/20/2015 | $220,032 |
| | 2015 | 2014 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | 00000 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 001 | 3 | NIH | 6/29/2015 | $0 |
| | 2015 | 2013 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | 00000 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 3 | NIH | 6/26/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $222,264 ) |
| | 2014 | 2014 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 3 | NIH | 8/14/2014 | $222,264 |
|
| Issue Date FY: 2013 ( Subtotal = $222,264 ) |
| | 2013 | 2013 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 3 | NIH | 7/1/2013 | $222,264 |
|
| Issue Date FY: 2012 ( Subtotal = $453,199 ) |
| | 2012 | 2012 | GOTEBORG UNIVERSITY | PO Box 100, SE-405 30 | GOTEBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 000 | 11 | NIH | 6/1/2012 | $230,935 |
| | 2012 | 2012 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 2 | NIH | 6/27/2012 | $222,264 |
| | 2012 | 2012 | GOTEBORG UNIVERSITY FAULTY OF MEDICINE | PO BOX 400 | COTERBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 001 | 11 | NIH | 7/5/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $458,431 ) |
| | 2011 | 2011 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | 00000 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 001 | 1 | NIH | 9/2/2011 | $226,800 |
| | 2011 | 2011 | GOTEBORG UNIVERSITY | PO Box 100, SE-405 30 | GOTEBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 000 | 10 | NIH | 6/8/2011 | $231,631 |
| | 2011 | 2011 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | 00000 | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 001 | 1 | NIH | 9/2/2011 | -$226,800 |
| | 2011 | 2011 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | | | SWE | U01AI095473 | The MUC2 Mucus Gel as an Innate Immune Mechanism that Inhibits Inflammation | 000 | 1 | NIH | 7/21/2011 | $226,800 |
|
| Issue Date FY: 2010 ( Subtotal = $236,249 ) |
| | 2010 | 2010 | GOTEBORG UNIVERSITY | PO Box 100, SE-405 30 | GOTEBORG | | - | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 002 | 9 | NIH | 6/14/2010 | $236,249 |
| | 2010 | 2008 | GOTEBORG UNIVERSITY FAULTY OF MEDICINE | PO BOX 400 | COTERBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 000 | 8 | NIH | 3/3/2010 | $0 |
| | 2010 | 2008 | GOTEBORG UNIVERSITY FAULTY OF MEDICINE | PO BOX 400 | COTERBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 001 | 8 | NIH | 6/11/2010 | $0 |
|
| Issue Date FY: 2007 ( Subtotal = $488,559 ) |
| | 2007 | 2007 | GOTEBORG UNIVERSITY FAULTY OF MEDICINE | PO BOX 400 | COTERBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 000 | 7 | NIH | 6/1/2007 | $226,389 |
| | 2007 | 2007 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | 00000 | | SWE | R01AI060688 | DEVELOPMENT OF KILLED VACCINE FOR VIBRIO CHOLERAE O139 | 000 | 2 | NIH | 5/16/2007 | $262,170 |
|
| Issue Date FY: 2006 ( Subtotal = $503,152 ) |
| | 2006 | 2006 | GOTEBORG UNIVERSITY FAULTY OF MEDICINE | PO BOX 400 | COTERBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 000 | 6 | NIH | 5/17/2006 | $233,152 |
| | 2006 | 2006 | UNIVERSITY OF GOTEBORG | BOX 100 SE-405 30 | GOTEBORG | | 00000 | | SWE | R01AI060688 | DEVELOPMENT OF KILLED VACCINE FOR VIBRIO CHOLERAE O139 | 000 | 1 | NIH | 4/28/2006 | $270,000 |
|
| Issue Date FY: 2005 ( Subtotal = $242,759 ) |
| | 2005 | 2005 | GOTEBORG UNIVERSITY FAULTY OF MEDICINE | PO BOX 400 | COTERBORG | | | | SWE | R01NS040863 | SPINAL INTERNEURONS: 5-HT-NA RECEPTORS, ACTIONS CIRCUITS | 000 | 5 | NIH | 9/12/2005 | $242,759 |
|
|
